e-learning
resources
Paris 2018
Tuesday, 18.09.2018
How far are we in terms of predicting mortality and exacerbations in COPD?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vitamin-D deficiency & anaemia in patients with acute exacerbations of COPD (AECOPD); morbidity & mortality.
N. Cafferky (Sunderland, United Kingdom), H. Shah (Sunderland, United Kingdom), S. Murphy (Sunderland, United Kingdom)
Source:
International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Session:
How far are we in terms of predicting mortality and exacerbations in COPD?
Session type:
Poster Discussion
Number:
3855
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Cafferky (Sunderland, United Kingdom), H. Shah (Sunderland, United Kingdom), S. Murphy (Sunderland, United Kingdom). Vitamin-D deficiency & anaemia in patients with acute exacerbations of COPD (AECOPD); morbidity & mortality.. 3855
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Vitamin D, exacerbations and hospitalizations in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014
Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015
One-year mortality in COPD patients after severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD?
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Is vitamin D deficiency a risk factor for COPD exacerbations?
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
PP307 – The role of microalbuminuria (MAB) in patients admitted for an Acute COPD Exacerbation (AECOPD)
Source: ERS Lung Science Conference 2021
Year: 2021
Vitamin D status in COPD patients admitted for exacerbation
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation
Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting
Year: 2012
Anemia predicts mortality after COPD exacerbation
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept